Active Ingredient: CYSTEINE HYDROCHLORIDE
Proprietary Name: ELCYS
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 500MG/10ML (50MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N210660
Product Number: 001
Approval Date: Apr 16, 2019
Applicant Holder Full Name: EXELA PHARMA SCIENCES LLC
Marketing Status:
Prescription
Patent and Exclusivity Information